Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 1
1 (50.0%)Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Phase 1
Completed
- Conditions
- Idiopathic Thrombocytopenic Purpura (ITP)Immune Thrombocytopenic Purpura (ITP)
- Interventions
- First Posted Date
- 2012-10-25
- Last Posted Date
- 2012-11-09
- Lead Sponsor
- Neufeld, Ellis J, MD, PhD
- Target Recruit Count
- 36
- Registration Number
- NCT01713738
- Locations
- 🇺🇸
UCLA, Mattel Children's Hospital, Los Angeles, California, United States
🇺🇸Stanford University School of Medicine, Palo Alto, California, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura
Not Applicable
Completed
- Conditions
- Idiopathic Thrombocytopenic PurpuraImmune Thrombocytopenic Purpura
- First Posted Date
- 2012-10-25
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- Neufeld, Ellis J, MD, PhD
- Target Recruit Count
- 10
- Registration Number
- NCT01713855
- Locations
- 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸Emory University School of Medicine, Atlanta, Georgia, United States
🇺🇸Children's Hospital, Boston, Massachusetts, United States
News
No news found